Scientists uncover how cancer cells hijack T-cells, making it harder for the body to fight back
Research led by the Chiba Cancer Center Research Institute in Japan has discovered a surprising way cancer evades the immune ...
Hosted on MSN17d
Candid Therapeutics signs $925m T cell engager deal with WuXi Biologics
US-based Candid Therapeutics has signed another T-cell engager (TCE) partnership, this time with Chinese biotech WuXi Biologics for the global rights to a preclinical asset. Under the deal, Candid ...